Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group

Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group

urpose: The medium-risk (IR) prostate cancer (PCa) are a heterogeneous group in terms of prognosis. For unfavorable or favorable IR PCa treated with radiotherapy, the remnants of the optimal strategy to be defined. In routine practice, doctor’s decision to propose hormonal therapy (HT) is controversial. PROACT survey aims to evaluate patterns and preferences of daily practice in France at this IR population.

Materials and Methods: A questionnaire was distributed to member web 91 French radiotherapy centers of the Groupe d’Etude des Tumeurs Uro-Genitales (GETUG). The questionnaire included four sections on: (i) specialists who prescribe treatment and multidisciplinary decision (MTD) validation; (Ii) the definition of patient subsets IR; (Iii) the parameters of radiotherapy; (Iv) regarding the practice patterns of cardiovascular (CV) and (iv) a metabolic evaluation. Descriptive presentation of the results is used.

Results: Among the 82 responses (90% of the centers), HT schedule and irradiation techniques validated by a particular board meeting in 54% and 45% of the center, respectively. Three-quarters (76%) of centers identify a subset of patients with IR to specific strategies. The majority of the center considers PSA> 15 (77%) and / or Gleason 7 (4 + 3) (87%) for the definition of IR unfavorable. Overall, 41% of the center is carried out systematically evaluate CV before HT prescription while 61% only consider CV history / status in defining the type of HT. LHRH agonists is often prescribed in both favorable (70%) and unfavorable (98%) patients with IR. Finally, weight loss (80%), metabolic profile (70%) and CV status (77%) of patients considered for follow-up under HT.

Conclusion: To the best of our knowledge, this is the first survey on practices in IR PCa HT. PROACT survey showed that three-quarters of respondents identified a subset of IR-patients in adjusting therapy. CV status of patients considered in guiding decisions HT, duration and type of .

Two professions against two killer diseases: reason, organizations, and the initial experience cardio-oncology services

Background: Cardiovascular disease (CV) is the most common factor affecting the prognosis in cancer patients. Cardio-oncology (CO) service has been developed to solve this problem. The lack of results regarding patient demographics and clinical findings applicable and available data is limited to the services CO evaluate patients undergoing chemotherapy only.

Purpose: To demonstrate initial experience CO service was conducted in a tertiary oncology centers.
Methods: CO Service is designed to include two major domains: general and consulting CO electrotherapy. Patients who are referred to a collection service CO with basic demographics, type of cancer, the reason for referral, cardiac evaluation, and initial clinical results were included in this observational study.
Results: All cancer patients referred to our CO service between March 2016 and December 2019 included in this study. A total of 2,762 (77% female) patients at a mean (SD) age of 62 (12) years referenced (63% on the basis of hospitalization) for public consultation.

The most frequent diagnosis was breast cancer (66%). In 18% of patients, the reason for referral to services CO is the treatment of cancer-related complications CV. A total of 652 patients (515 patients with cardiac implantable electronic device (CIED) eligible for radiotherapy (RT), 48 patients with diagnosed CIEDs by magnetic resonance imaging (MRI), and 89 patients with cancer treated with surgery CIED) were evaluated by a team CO- CIED. During the 5872 session of the RT total, two dangerous interactions and no other complications during MRI and surgery were recorded.

Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group

Diet Association Quality With Survival Among People With Metastatic Colorectal Cancer at the Cancer and Leukemia Group B and the Southwest Oncology 80 405 Experiment

Importance: Diet has been associated with survival in patients with stage I to III colorectal cancer, but the data in patients with metastatic colorectal cancer are limited.
Objective: To examine the relationship between diet quality and overall survival among individuals with metastatic colorectal cancer.

Design, setting, and participants: This study is a prospective cohort study of patients with metastatic colorectal cancer enrolled in the Cancer and Leukemia Group B (Alliance) and the Southwest Oncology Group 80 405 trials between 27 October 2005 and 29 February 2012, and followed up through January 2018 ,
Exposure: Participants completed a validated food frequency questionnaire within 4 weeks after starting first-line treatment for metastatic colorectal cancer. Diet categorized according to the Alternative Healthy Eating Index (AHEI), Alternative Mediterranean Diet (AMED) score, diet Approaches to Stop Hypertension (DASH) score, and Western and prudent dietary pattern derived using principal component analysis. Participants were classified into sex-specific quintiles.

The main results and measures: multivariable hazard ratio (HR) and 95% CI for overall survival.

Recombinant Human KDR/VEGFR-2/FLK-1(C-6His)

CB26-500ug 500ug
EUR 1613
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Human KDR/VEGFR-2/FLK-1(C-6His)

CB26-50ug 50ug
EUR 496
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Mouse Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 ELISA kit

CSB-E04764m-24T 1 plate of 24 wells
EUR 165
Description: Quantitative sandwich ELISA kit for measuring Mouse Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 ELISA kit

1-CSB-E04764m
  • EUR 703.00
  • EUR 4843.00
  • EUR 2570.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitative sandwich ELISA kit for measuring Mouse Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Mouse Vascuoar endothelial cell growth factor receptor 2((VEGFR-2/Flk-1)ELISA Kit

GA-E0681MS-48T 48T
EUR 336

Mouse Vascuoar endothelial cell growth factor receptor 2((VEGFR-2/Flk-1)ELISA Kit

GA-E0681MS-96T 96T
EUR 534

VEGFR-2, human recombinant protein

P1080-.1 100 µg
EUR 1929
Description: Vascular endothelial growth factor receptor 2 (VEGFR-2) belongs to the family of receptor tyrosine kinases (RTKs) and is almost exclusively restricted to endothelial cells. VEGFR-2 has a lower affinity for VEGF than the Flt-1 receptor, but a higher signaling activity

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

ELISA kit for Mouse Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE71214-48T 48T
EUR 332
Description: Quantitative sandwich ELISA for measuring Mouse Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE71214-5platesof96wells 5 plates of 96 wells
EUR 2115
Description: Quantitative sandwich ELISA for measuring Mouse Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE71214-96T 96T
EUR 539
Description: Quantitative sandwich ELISA for measuring Mouse Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Anti-Flk-1 Antibody

A00901 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Flk-1 Antibody (KDR) detection.tested for WB in Human, Mouse, Rat.

Anti-Flk-1 antibody

STJ98079 100 µl
EUR 234
Description: Mouse monoclonal to Flk-1.

Anti-Flk-1 antibody

STJ93087 200 µl
EUR 197
Description: Rabbit polyclonal to Flk-1.

Anti-Flk-1 antibody

STJ93088 200 µl
EUR 197
Description: Flk-1 is a protein encoded by the KDR gene which is approximately 151,5 kDa. Flk-1 isoform 1 is localised to the cell membrane and isoform 2 and 3 are secreted. It is involved in apoptotic pathways, the GPCR pathway, ERK signalling and the CREB pathway. This receptor is one of two type III receptor tyrosine kinase that functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor. Flk-1 is widely expressed in human tissues including the cornea. Mutations in the KDR gene may result in hemangioma. STJ93088 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of Flk-1 protein.

Anti-Flk-1 antibody

STJ93089 200 µl
EUR 197
Description: Rabbit polyclonal to Flk-1.

Anti-Flk-1 antibody

STJ93090 200 µl
EUR 197
Description: Rabbit polyclonal to Flk-1.

Human Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 ELISA kit

CSB-E04763h-24T 1 plate of 24 wells
EUR 165
Description: Quantitative sandwich ELISA kit for measuring Human Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 ELISA kit

1-CSB-E04763h
  • EUR 602.00
  • EUR 4238.00
  • EUR 2256.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitative sandwich ELISA kit for measuring Human Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Rat Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 ELISA kit

CSB-E07348r-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Rat Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Rat Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 ELISA kit

1-CSB-E07348r
  • EUR 703.00
  • EUR 4843.00
  • EUR 2570.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Rat Vascular endothelial cell growth factor receptor 2, VEGFR-2/Flk-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human Vascuoar endothelial cell growth factor receptor 2,VEGFR-2/Flk-1 ELISA kit

201-12-0248 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Vascuoar endothelial cell growth factor receptor 2(VEGFR-2/Flk-1)ELISA Kit

GA-E0264HM-48T 48T
EUR 289

Human Vascuoar endothelial cell growth factor receptor 2(VEGFR-2/Flk-1)ELISA Kit

GA-E0264HM-96T 96T
EUR 466

Human Vascuoar endothelial cell growth factor receptor 2(VEGFR-2/Flk-1)ELISA Kit

QY-E00704 96T
EUR 361

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 280

ELISA kit for Human Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE61925-48T 48T
EUR 332
Description: Quantitative sandwich ELISA for measuring Human Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE61925-5platesof96wells 5 plates of 96 wells
EUR 2115
Description: Quantitative sandwich ELISA for measuring Human Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE61925-96T 96T
EUR 539
Description: Quantitative sandwich ELISA for measuring Human Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Rat Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE100727-48T 48T
EUR 381
Description: Quantitative sandwich ELISA for measuring Rat Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Rat Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE100727-5platesof96wells 5 plates of 96 wells
EUR 2662
Description: Quantitative sandwich ELISA for measuring Rat Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Rat Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1)

KTE100727-96T 96T
EUR 669
Description: Quantitative sandwich ELISA for measuring Rat Vascular endothelial cell growth factor receptor 2 (VEGFR-2/Flk-1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Vascular endothelial cell growth factor receptor 2,VEGFR-2/Flk-1

EK0298 96 tests
EUR 712
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Vascular endothelial cell growth factor receptor 2,VEGFR-2/Flk-1 in samples from serum, plasma, tissue homogenates and other biological fluids.

Anti-VEGFR-1/FLT-1 antibody

PAab09393 100 ug
EUR 355

anti- VEGFR-1/FLT-1 antibody

FNab09393 100µg
EUR 505.25
Description: Antibody raised against VEGFR-1/FLT-1

Mouse FLT-4/VEGFR-3 Control/blocking peptide #1

FLT41-P 100 ug
EUR 164

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

VEGFR Tyrosine Kinase Inhibitor II

C4603-1 1 mg
EUR 118

Human FLT-1/VEGFR-1 Control/blocking peptide #1

FLT11-P 100 ug
EUR 164

VEGFR-1 Antibody

48347-100ul 100ul
EUR 333

VEGFR-1 Antibody

48347-50ul 50ul
EUR 239

Anti-Flk-1/Flt-4 antibody

STJ93091 200 µl
EUR 197
Description: Rabbit polyclonal to Flk-1/Flt-4.

Anti-Phospho-Flk-1 (Y1175) antibody

STJ90270 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-Flk-1 (Y1175).

Anti-Phospho-Flk-1 (Y1214) antibody

STJ90271 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-Flk-1 (Y1214).

Anti-Phospho-Flk-1 (Y951) antibody

STJ90272 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-Flk-1 (Y951).

Anti-Phospho-Flk-1 (Y1059) antibody

STJ90482 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-Flk-1 (Y1059).

Human/Rat/Mouse PLP139-151 (C140) peptide, depalmitoylated

PLP139-2-1 1 mg
EUR 141

Rat Anti-Mouse VEGFR-2 Monoclonal antibody, clone DC101

CABT-L4382-1mg 1 mg
EUR 897

Rat Anti-Mouse VEGFR-2 Monoclonal antibody, clone DC101

CABT-L4382-5mg 5 mg
EUR 2405

VEGFR-1/Flt1/ Rat VEGFR- 1/ Flt1 ELISA Kit

ELA-E0147r 96 Tests
EUR 886

VEGFR-2-IN-5

HY-18625 100mg
EUR 2943

KDR / VEGFR-2 Antibody

48311-100ul 100ul
EUR 333

KDR / VEGFR-2 Antibody

48311-50ul 50ul
EUR 239

Human FLT-4/VEGFR-3 control/blocking peptide #2

FLT42-P 100 ug
EUR 164

Mouse VEGFR-1/Flt1 ELISA Kit

EMV0045 96Tests
EUR 521

Anti-Adiponectin Receptor 2 (mouse) Antibody

A02218-2 200ug
EUR 498
Description: Goat Polyclonal Adiponectin Receptor 2 (mouse) Antibody. Validated in IF, IHC and tested in Mouse.

VEGFR-1 / FLT-1 Antibody

abx239393-100ug 100 ug
EUR 481

VEGF receptor KDR/Flk-1 (K237), Peptide Aptamer, Biotinylated

AP-336-B 1 mg Ask for price

VEGF receptor KDR/Flk-1 (K237), Peptide Aptamer, unlabeled

AP-336-U 5 mg Ask for price

Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG, aff pure

FLT12-M 100 ug
EUR 482

Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG, aff pure

FLT14-M 100 ug
EUR 482

Flk 1 antibody (allophycocyanin)

61R-1777 50 ug
EUR 478
Description: Rat monoclonal Flk 1 antibody (allophycocyanin)

Flk-1 Polyclonal Antibody

ABP51352-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse. This Flk-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y951

Flk-1 Polyclonal Antibody

ABP51352-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse. This Flk-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y951

Flk-1 Polyclonal Antibody

ABP51352-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse. This Flk-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y951

Flk-1 Polyclonal Antibody

ABP51353-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1059

Flk-1 Polyclonal Antibody

ABP51353-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1059

Flk-1 Polyclonal Antibody

ABP51353-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1059

Flk-1 Polyclonal Antibody

ABP55018-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1214

Flk-1 Polyclonal Antibody

ABP55018-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1214

Flk-1 Polyclonal Antibody

ABP55018-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1214

Flk-1 Polyclonal Antibody

ABP55019-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1175

Flk-1 Polyclonal Antibody

ABP55019-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1175

Flk-1 Polyclonal Antibody

ABP55019-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of Flk-1 from Human, Mouse, Rat. This Flk-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Flk-1 around the non-phosphorylation site of Y1175

Flk-1 Polyclonal Antibody

ES6017-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Flk-1 Polyclonal Antibody

ES6017-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Flk-1 Polyclonal Antibody

ES6018-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Flk-1 Polyclonal Antibody

ES6018-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Flk-1 Polyclonal Antibody

ES2351-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Flk-1 Polyclonal Antibody

ES2351-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Flk-1 Polyclonal Antibody

ES2352-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Flk-1 Polyclonal Antibody

ES2352-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Flk-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Flk-1 Polyclonal Antibody

40929-100ul 100ul
EUR 252

Flk-1 Polyclonal Antibody

40929-50ul 50ul
EUR 187

Flk-1 Polyclonal Antibody

40930-100ul 100ul
EUR 252

Flk-1 Polyclonal Antibody

40930-50ul 50ul
EUR 187

KDR / VEGFR-2 Conjugated Antibody

C48311 100ul
EUR 397

VEGFR-2, human recombinant protein

P1080-.01 10 µg
EUR 313
Description: Vascular endothelial growth factor receptor 2 (VEGFR-2) belongs to the family of receptor tyrosine kinases (RTKs) and is almost exclusively restricted to endothelial cells. VEGFR-2 has a lower affinity for VEGF than the Flt-1 receptor, but a higher signaling activity

Custom Anti-Peptide antibodies, 2 peptides (upto 20-aa; synthesis, 2 conjugation, 2 rabbits, 2 ELISA)

ABPEP-20-2 1
EUR 2356

miRZip-92-2* anti-miR-92-2* microRNA star construct

MZIP92-2*-PA-1 Bacterial Streak
EUR 684

Rabbit Anti-Mouse FLT-1/VEGFR-1 (279-299aa) IgG, aff pure

FLT15-A 100 ul
EUR 482

Mouse C-Peptide ELISA Kit

DLR-C-Peptide-Mu-48T 48T
EUR 450
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse C-Peptide ELISA Kit

DLR-C-Peptide-Mu-96T 96T
EUR 582
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse C-Peptide ELISA Kit

RD-C-Peptide-Mu-48Tests 48 Tests
EUR 446

Mouse C-Peptide ELISA Kit

RD-C-Peptide-Mu-96Tests 96 Tests
EUR 615

Mouse C-Peptide ELISA Kit

RDR-C-Peptide-Mu-48Tests 48 Tests
EUR 465

Mouse C-Peptide ELISA Kit

RDR-C-Peptide-Mu-96Tests 96 Tests
EUR 643

VEGF receptor KDR/Flk-1 (K237), Peptide Aptamer, FITC labelled

AP-336-F 1 mg Ask for price

Custom Anti-Peptide antibodies 2 peptides (upto 20-aa, synthesis, 2 conjugation, 2 rabbits, 2 ELISA & 2 Aff. Purif.)

ABPEP-20A-2 1
EUR 3806

Rabbit Anti-Mouse FLT-4/VEGFR-3 IgG #1, aff pure

FLT41-A 100 ug
EUR 482

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

Anti-Peptide YY/PYY Antibody

A04223-1 100ug/vial
EUR 334

Mouse VEGFR 3 ELISA Kit

EMV0018 96Tests
EUR 521

VEGFR ELISA Kit (Mouse) (OKDD00885)

OKDD00885 96 Wells
EUR 557
Description: Description of target: ;Species reactivity: Mouse;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: <0.062ng/mL

Flk-1 Polyclonal Conjugated Antibody

C40929 100ul
EUR 397

Rabbit Anti-human FLT-1/VEGFR-1 IgG #1, aff pure

FLT11-A 100 ul
EUR 482

Anti-HO-1 Monoclonal Antibody (HO-1-2)

M00253-1 1mg
EUR 397
Description: Mouse Monoclonal HO-1 Antibody (HO-1-2). Validated in Flow Cytometry, IHC, WB and tested in Human, Mouse, Rat.

VEGFR-2 ELISA Kit (Rabbit) (OKWB00421)

OKWB00421 96 Wells
EUR 572
Description: Description of target: ;Species reactivity: Rabbit;Application: ;Assay info: Assay Type: Quantitative Sandwich ELISA;Sensitivity: 0.094 ng/mL

Autocamtide-2-related inhibitory peptide

B6831-1 1 mg
EUR 154
Description: IC50: 40 nM for CaM-kinase II [1].

Custom Anti-Peptide antibodies, 2 peptides (upto 20-aa; synthesis,2 conjugation, 2 rabbits, 2 ELISA & 1 Aff purif)

ABPEP-20A-1 1
EUR 3081

Anti-ErbB 2/ERBB2 Antibody

A00010-2 100ug/vial
EUR 334

Anti-Bcl-2/BCL2 Antibody

A00040-2 100ug/vial
EUR 334

Anti-Angiopoietin-2/ANGPT2 Antibody

A00370-2 100ug/vial
EUR 334

Anti-EIF4A1/2/3 Antibody

A03922-2 100ug/vial
EUR 334

Anti-Fascin 2/FSCN2 Antibody

A07840-2 100ug/vial
EUR 294

Anti-Phospho-Flk-1/Flt-4 (Y1054/Y1063) antibody

STJ91156 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-Flk-1/Flt-4 (Y1054/Y1063).

Anti-Galectin 1 Antibody

A00470-2 100ug/vial
EUR 294

Anti-Oct-1 Antibody

A01766-2 100ul
EUR 397
Description: Rabbit Polyclonal Oct-1 Antibody. Validated in IF, WB and tested in Human, Mouse.

VEGFR-3 Antibody

21410-100ul 100ul
EUR 252

VEGFR-3 Antibody

21410-50ul 50ul
EUR 187

Vandetanib (VEGFR inhibitor)

SIH-483-10MG 10 mg
EUR 121
Description: The substance Vandetanib is a vegfr inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (30 mg/ml) or EtOH (10 mg/ml).

Vandetanib (VEGFR inhibitor)

SIH-483-50MG 50 mg
EUR 289
Description: The substance Vandetanib is a vegfr inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (30 mg/ml) or EtOH (10 mg/ml).

Anti-CCR4 (mouse) Antibody

A00755-2 200ug
EUR 397
Description: Goat Polyclonal CCR4 (mouse) Antibody. Validated in ELISA, IF, IHC and tested in Mouse.

Rabbit VEGFR-1/Flt1 ELISA Kit

ERTV0045 96Tests
EUR 521

Rat VEGFR-1/Flt1 ELISA Kit

ERV0045 96Tests
EUR 521

Porcine VEGFR-1/Flt1 ELISA Kit

EPV0045 96Tests
EUR 521

Goat VEGFR-1/Flt1 ELISA Kit

EGTV0045 96Tests
EUR 521

Human VEGFR-1/Flt1 ELISA Kit

EHV0045 96Tests
EUR 521

Bovine VEGFR-1/Flt1 ELISA Kit

EBV0045 96Tests
EUR 521

Canine VEGFR-1/Flt1 ELISA Kit

ECV0045 96Tests
EUR 521

Anserini VEGFR-1/Flt1 ELISA Kit

EAV0045 96Tests
EUR 521

Anti-COX2/Cyclooxygenase 2/PTGS2 Antibody

A00084-2 100ug/vial
EUR 294

Results: In a cohort study of 1284 individuals with metastatic colorectal cancer, the median age was 59 (interquartile range [IQR]: 51-68) years, body mass index, the average was 27.2 (IQR, 24.1 to 31, 4), 521 (41%) were women, and in 1102 (86%) were white. There are 1100 deaths during a median follow-up of 73 months (IQR, 64-87 months). We observed an inverse relationship between a score of AMED and the risk of death (HR quintile 5 vs first quintile, 0.83; 95% CI, 0.67 to 1.04; P = 0.04 for trend), but the estimate is not statistically significant point , None of the other diet or pattern values ​​associated with overall survival.

Conclusion and relevance: In this prospective analysis of patients with metastatic colorectal cancer, diet quality were assessed at start of first-line treatment for metastatic disease was not associated with overall survival.

Related Posts

Leave a Reply

Your email address will not be published.